---
name: LGM Pharma
slug: lgmpharma
site: cdmo
website_domain: lgmpharma.com
summary: LGM Pharma offers full-service CDMO support from concept through commercialization, plus API sourcing. It provides analytical method development and stability testing for APIs and drug products, with regulatory strategy support for 505(b)(2) and ANDA filings.
tagline: Tailored API sourcing and CDMO services for the full drug product lifecycle
founded_year: 
employee_count_band: 
employee_count_label: 
parent_name: 
parent_slug: 
hq_country: 
tier2_domain_verified: false
updated_at: 2026-11-01T07:01:21.355Z
services_count: 4
modalities_count: 1
indications_count: 0
locations_count: 0
review_signal_gate: closed
generated_by: BioBM Editorial AI
---

# LGM Pharma

Tailored API sourcing and CDMO services for the full drug product lifecycle

Listed on cdmo.directory.

## Summary

LGM Pharma offers full-service CDMO support from concept through commercialization, plus API sourcing. It provides analytical method development and stability testing for APIs and drug products, with regulatory strategy support for 505(b)(2) and ANDA filings.

## Services

- CMC Analytical Development
- Stability Testing & Storage
- CMC Regulatory Submission Support
- Quality Control Testing

## Modalities

- Small Molecule

## Long description

## Overview

LGM Pharma describes itself as a provider of tailored API and CDMO services for the full drug product lifecycle.

## Services

- **CDMO services:** Full-service CDMO support intended to take a product from concept through commercialization, across dosage forms.
- **API sourcing:** Relationships with manufacturers worldwide, presented as a way to reduce supply chain risk and improve access to high-quality APIs.
- **API products:** Securing, importing, and delivering niche or complex active pharmaceutical ingredients.
- **Analytical services:** Analytical method development and stability testing for APIs and drug products.

## Regulatory approach

The site states that it provides a tailored regulatory strategy supported by in-house experts working with R&D. It references 505(b)(2) projects, ANDAs, controlled substances, and HPAPIs as areas of experience, with a focus on FDA-approved cGMP manufacturing.

## Related companies

- [Interlabor Belp AG](/companies/interlabor-belp-ag) (CMC Analytical Development, Stability Testing & Storage) — [Compare](/compare/interlabor-belp-ag/lgmpharma)
- [Codis](/companies/codis) (CMC Analytical Development, Stability Testing & Storage) — [Compare](/compare/codis/lgmpharma)
- [Glatt](/companies/glatt) (CMC Analytical Development, Stability Testing & Storage) — [Compare](/compare/glatt/lgmpharma)
- [ARSI Canada Inc](/companies/arsicanada) (CMC Analytical Development, Stability Testing & Storage) — [Compare](/compare/arsicanada/lgmpharma)
- [Dipharma](/companies/dipharma) (CMC Analytical Development, CMC Regulatory Submission Support) — [Compare](/compare/dipharma/lgmpharma)
- [Alfa Chemistry](/companies/alfa-chemistry) (CMC Analytical Development, Quality Control Testing) — [Compare](/compare/alfa-chemistry/lgmpharma)
- [Ethypharm](/companies/ethypharm) (Stability Testing & Storage, CMC Regulatory Submission Support) — [Compare](/compare/ethypharm/lgmpharma)
- [CMC Pharmaceuticals, Inc.](/companies/cmcpharm) (CMC Analytical Development, Stability Testing & Storage) — [Compare](/compare/cmcpharm/lgmpharma)

_Profile last updated: 2026-11-01T07:01:21.355Z. Profile facts may include AI-assisted enrichment._

Auto-generated by BioBM Editorial AI for machine-readable profile access.